Ma hea e kūʻai ai iā Lorcaserin a me kāna mau waena?

Hiki iā ʻoe ke kūʻai i kahi lorcaserin e kūʻai ai ma nā hale kūʻai pūnaewele. Loaʻa ka pauka i ka nui no nā mea noiʻi a me nā loiloi. Ke lilo kāu pahuhopu i nā paona keu no ka momona, hiki iā ʻoe ke nānā iā lorcaserin no ke kūʻai aku ma ka pūnaewele. Eia nō naʻe, koi paha ʻoe i kahi kuhikuhi ma muli o nā alakaʻi koʻikoʻi e ka FDA.
Inā ʻoe e ʻimi nei i ka lorcaserin a i ʻole kāna mau waena, pono ʻoe e nānā me CMOAPI no kahi lako kūpono o nā huahana maʻemaʻe. Ua hōʻoia kā mākou mau hui i ka hōʻoia maikaʻi.

( 1 )↗

Punawai Haumana

PubMed Central

Ua mahalo nui ʻia mai ka National Institutes of Health
E hele i ke kumu

ʻO Lorcaserin-Infographic-01 ʻO Lorcaserin-Infographic-02 ʻO Lorcaserin-Infographic-03

ʻO Lorcaserin FAQ

Pehea wau e lawe ai i ka belviq no nā hopena maikaʻi?

E ale i ka papala hoʻolōʻihi a hoʻolōʻihi ʻia a mai haki, nāwaliwali, a haki hoʻi. Hiki iā ʻoe ke lawe iā Belviq me ka ʻole o ka meaʻai. Pono ʻoe e lilo ma ka liʻiliʻi he 5% o kāu kaupaona hoʻomaka i nā hebedoma he 12 o ka lawe ʻana iā Belviq a ʻai i ka papa calorie haʻahaʻa.

Ehia mau kaumaha āu e lilo ai me belviq?

ʻO Lorcaserin, hoʻohana pū ʻia me ka papaʻai a me ka hoʻoikaika kino, nā hopena i ka hoʻemi haʻahaʻa haʻahaʻa ma kahi o 12.9 lb (5.8 kg) i hoʻohālikelike ʻia me 5.6 lb (2.5 kg) me kahi placebo.

Pehea ka lōʻihi e lawe ai ʻoe i belviq?

Hiki iā ʻoe ke lawe iā Belviq me ka ʻole o ka meaʻai. Pono ʻoe e lilo ma ka liʻiliʻi he 5% o kāu kaupaona hoʻomaka i nā hebedoma he 12 o ka lawe ʻana iā Belviq a ʻai i ka papa calorie haʻahaʻa. Kāhea i kāu kauka inā ʻaʻole ʻoe e nalo ma ka liʻiliʻi 5% o kāu kaupaona hoʻomaka ma hope o ka lawe ʻana i ka lāʻau no 12 mau pule.

Pehea ʻoe e belviq?

ʻIke ʻia ʻo Belviq ma ke ʻano he agonist receptor serotonin 2C wae, ʻo ia hoʻi ke hoʻoulu nei i nā ʻāpana kikoʻī o kou lolo e hōʻoluʻolu ai iā ʻoe. ʻO ka pōloli liʻiliʻi e alakaʻi i ka liʻiliʻi o ka ʻai, kahi e alakaʻi ai i ka pohō kaumaha.

( 2 )↗

Punawai Haumana

PubMed Central

Ua mahalo nui ʻia mai ka National Institutes of Health
E hele i ke kumu

He aha nā hopena o ka lorcaserin?

ʻO nā hopena ʻē aʻe o Belviq e komo pū me: ke kō kō kō (haʻahaʻa i ke kō)

Hiki iā ʻoe ke inu wai ʻona i ka wā e lawe ana i ka belviq?

Hana pū nā lāʻau hoʻohaʻahaʻa kaumaha āpau me ka waiʻona? ʻAʻole nā ​​lāʻau lapaʻau kaumaha a pau i ka launa pū ʻana me ka waiʻona; ʻo kahi laʻana, ʻo lorcaserin (Belviq, Belviq XR) a me orlistat (Alli, Xenical) mai papa inoa ʻole i nā launa lāʻau ʻawa i kā lākou lepili huahana.

Hiki iā belviq ke kumu i ka loaʻa kālā?

Nā hopena wiwi. ʻO ka poʻe e ʻai i ka lāʻau no hoʻokahi makahiki hiki ke manaʻo e lilo i ka 3 a i ka 3.7 pakeneka wale nō o ko lākou kaumaha, a loaʻa paha iā lākou ke kaupaona, e ʻōlelo ana ka noiʻi. I hoʻokahi hoʻokolokolo, nalowale nā ​​mea maʻi e lawe ana iā Belviq a i ka 5 pākēneka o ko lākou kino kaumaha ma hope o 12 mau mahina, akā ua loaʻa ka 25 pākēneka i ka hopena o ka makahiki ʻelua.

ʻO wai ka maikaʻi ʻo Contrave a i ʻole belviq?

No Belviq lāua ʻo Contrave i nā papa lāʻau like ʻole. ʻO Belviq kahi serotonin 2C receptor agonist a ʻo Contrave kahi hui o kahi opioid antagonist a me kahi antidepressant.

Hana maoli paha ʻo belviq?

ʻO ka poʻe e lawe ana i ka lāʻau no hoʻokahi makahiki hiki ke manaʻo e lilo wale iā 3 a i ka 3.7 pakeneka o ko lākou kaumaha

Ua like ka belviq me Phentermine?

Hoʻohana ʻia ʻo Belviq (lorcaserin hydrochloride) a me Adipex-P (phentermine) no ka mālama ʻana i ke kaupaona i nā mea maʻi momona me ka hoʻohui i ka papaʻai a me ka hoʻoikaika kino. Hoʻohana ʻia ʻo Belviq no ka hoʻokele kaumaha mau.

Ua hoʻopau ʻia ʻo belviq?

Ua noi aku ka US Food and Drug Administration (FDA) e hana manawaleʻa ka mea hana o Belviq, Belviq XR (lorcaserin) i ka lāʻau hōʻemi kaumaha mai ka mākeke US.

( 3 )↗

Punawai Haumana

PubMed Central

Ua mahalo nui ʻia mai ka National Institutes of Health
E hele i ke kumu

E hoʻomaopopo '

  1. ʻO Taylor, J., Dietrich, E., and Powell, J. (2013). Lorcaserin no ka mālama ʻana i ke kaupaona. Diabetes, Metabolic Syndrome, a me ka momona.
  2. Hoy, SM (2013). Lorcaserin: ʻO kahi loiloi o kāna hoʻohana i ka mālama kaumaha kaumaha. Nā lāʻau.
  3. ʻO Hess, R., a me Cross, LB (2013). Ka palekana a me ka pono o Lorcaserin i ka hoʻokele o ka momona. Lapaʻau laepua.
  4. Brashier, DB, Sharma, AK, Dahiya, N., and Singh, SK (2014). Lorcaserin: He lāʻau lapaʻau Antiobesity Novel. Ka Nupepa o Pharmacology & Pharmacotherapeutics.
  5. Chan, EW et al. (2013). Ka maikaʻi a me ka palekana o Lorcaserin i nā mākua Obese: kahi Meta-Analysis o nā 1-Year Randomized Controlled Trials (RCTs) a me ka Narrative Review on Short-Term RCTs. ʻO nā loiloi Obese.
  6. Nigro, SC, Luon, D., and Baker, WL (2013). Lorcaserin: A Novel Serotonin 2C Agonist no ka mālama ʻana i ka momona. ʻO ka noiʻi noiʻi olakino o kēia manawa a me ka manaʻo.